At the Edwards-Hunt Group, we have participated in the clinical trials industry’s evolution from paper-only processes to include digital mediums (such as iPad for consent) to remote trials. We have been on the edge of this industry trend helping to improve trial efficiency with technology while ensuring Good Clinical Practice is maintained. Our team has developed processes to support our client’s hybrid and fully-remote clinical trial activities in a manner compliant with US regulations. We have repeatedly demonstrated our expertise by adding the complexity of biospecimen collection to the virtual research setting which requires an understanding of the participant’s disease and quality of life coupled with the scientific necessity for highly-annotated specimens.
The Edwards-Hunt Group combines experience and knowledge of the healthcare and technology industries with business methodologies to develop and integrate solutions for our clients’ translational medicine programs. We are uniquely positioned to understand our clients’ relationships with their constituents and business partners. Our background enables us to manage programs from concept to completion and navigate partner relations to meet and exceed your business objectives.
We employ a thoughtful, efficient approach to achieve maximum results for our clients. Our staff combine strategic development with tactical implementation providing a turn key approach to program development. Through an understanding of our clients’ core values and mission, we effectively implement solutions tailored to achieve our client’s specific goals. Our practice centers on supporting the following:
Edwards-Hunt Group offers to the biopharmaceutical and diagnostic companies prospective collection of human tissues for research. Our goal is to facilitate the collection, storage and distribution of biospecimens collected under U.S. regulatory standards. Through our expansive, international network, we are able to offer timely collection of high quality, highly annotated biospecimens to accommodate research applications used in the drug discovery and the drug/device development process. We offer contract research organization services including regulatory package development, site identification, study management, data collection and monitoring.
The Edwards-Hunt Group has successfully collaborated with non-profit organizations to achieve their translational medicine goals by providing a host of services from strategic planning, program development, technology and human resource management.
We assist the biorepository industry; whether non-profit or commercial, achieve their objectives by providing a full range of services from strategic development through tactical implementation. Including the following:
We believe the efficient implementation of a biobanking technology solution, tailored to meet the end user’s business requirements, is critical to supporting the drug development process. We provide a broad range of services to the technology industry including: